Hainan Poly Pharm. Co., Ltd

SZSE:300630 Stock Report

Market Cap: CN¥5.2b

Hainan Poly Pharm Balance Sheet Health

Financial Health criteria checks 2/6

Hainan Poly Pharm has a total shareholder equity of CN¥2.8B and total debt of CN¥2.7B, which brings its debt-to-equity ratio to 96.7%. Its total assets and total liabilities are CN¥6.3B and CN¥3.4B respectively.

Key information

96.7%

Debt to equity ratio

CN¥2.72b

Debt

Interest coverage ration/a
CashCN¥331.37m
EquityCN¥2.81b
Total liabilitiesCN¥3.45b
Total assetsCN¥6.25b

Recent financial health updates

No updates

Recent updates

What Hainan Poly Pharm. Co., Ltd's (SZSE:300630) 46% Share Price Gain Is Not Telling You

Oct 08
What Hainan Poly Pharm. Co., Ltd's (SZSE:300630) 46% Share Price Gain Is Not Telling You

Hainan Poly Pharm. Co., Ltd (SZSE:300630) Stocks Shoot Up 28% But Its P/E Still Looks Reasonable

Aug 16
Hainan Poly Pharm. Co., Ltd (SZSE:300630) Stocks Shoot Up 28% But Its P/E Still Looks Reasonable

It's Down 27% But Hainan Poly Pharm. Co., Ltd (SZSE:300630) Could Be Riskier Than It Looks

Apr 21
It's Down 27% But Hainan Poly Pharm. Co., Ltd (SZSE:300630) Could Be Riskier Than It Looks

A Piece Of The Puzzle Missing From Hainan Poly Pharm. Co., Ltd's (SZSE:300630) 27% Share Price Climb

Mar 06
A Piece Of The Puzzle Missing From Hainan Poly Pharm. Co., Ltd's (SZSE:300630) 27% Share Price Climb

Financial Position Analysis

Short Term Liabilities: 300630's short term assets (CN¥2.2B) exceed its short term liabilities (CN¥1.4B).

Long Term Liabilities: 300630's short term assets (CN¥2.2B) exceed its long term liabilities (CN¥2.1B).


Debt to Equity History and Analysis

Debt Level: 300630's net debt to equity ratio (84.9%) is considered high.

Reducing Debt: 300630's debt to equity ratio has increased from 12.7% to 96.7% over the past 5 years.

Debt Coverage: 300630's operating cash flow is negative, therefore debt is not well covered.

Interest Coverage: Insufficient data to determine if 300630's interest payments on its debt are well covered by EBIT.


Balance Sheet


Discover healthy companies